Published in Medical Letter on the CDC and FDA, April 9th, 2006
According to recent research from the United States, "A collagen-glycosaminoglycan biodegradable matrix (Integra Bilayer Matrix Wound Dressing, Integra LifeSciences, Plainsboro, NJ) has been approved by the U.S. Food and Drug Administration for treatment of full-thickness burns. Since its introduction, many centers have expanded its use to include chronic wounds. The economic impact of using collagen-glycosaminoglycan biodegradable matrix, however, has not been evaluated."
"The authors present a retrospective case-matched study designed to compare the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.